Access the Webinar Recording
Fortifying your 340B drug pricing program can drive significant savings for your hospital or health system's bottom line. Evolving regulatory scrutiny by the Office of Inspector General, Health Resources and Services Administration (HRSA), among others present challenges to achieving program compliance. BDO will discuss how organizations can assess program compliance, identify disclosure requirements and enhance their 340B program.
Managing Director and National Healthcare Compliance and Regulatory Leader